Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Sampatrilat is an effecive and orally active vasopeptidase inhibitor of ACE and neutral endopeptidase. Sampatrilat inhibits C-domain ACE (Ki=13.8 nM) 12.4-fold more potent than that for the N-domain (Ki=171.9 nM).
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約8-10 週間 | ¥ 418,000 |
50 mg | 約8-10 週間 | ¥ 546,500 |
100 mg | 約8-10 週間 | ¥ 711,500 |
説明 | Sampatrilat is an effecive and orally active vasopeptidase inhibitor of ACE and neutral endopeptidase. Sampatrilat inhibits C-domain ACE (Ki=13.8 nM) 12.4-fold more potent than that for the N-domain (Ki=171.9 nM). |
ターゲット&IC50 | nACE:171.9 nM(ki), CACE:(ki)13.8 nM |
In vivo | Sampatrilat (p.o.; 30 mg/kg; once a day; 5 weeks) decreases the mortality of the rats with CAL (20% versus 57% for untreated rats) and increase in the survival rate and improvement of the hemodynamic function of the rats with CAL [2]. |
別名 | UK-81252 |
分子量 | 584.68 |
分子式 | C26H40N4O9S |
CAS No. | 129981-36-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Sampatrilat 129981-36-8 Others UK-81252 UK81252 UK 81252 Inhibitor inhibitor inhibit